# Vascular Effects of Hesperidin in Metabolic Syndrome

> **NCT00914251** · PHASE2 · UNKNOWN · sponsor: **University of Rome Tor Vergata** · enrollment: 30 (estimated)

## Conditions studied

- Endothelial Dysfunction
- Metabolic Syndrome

## Interventions

- **DRUG:** Hesperidin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00914251
- **Lead sponsor:** University of Rome Tor Vergata
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-11
- **Primary completion:** 2009-03
- **Final completion:** 2010-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2009-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00914251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00914251, "Vascular Effects of Hesperidin in Metabolic Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00914251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*